跳至主要内容
临床试验/NCT02257983
NCT02257983已完成2 期

A Phase 2A Randomized, Placebo Controlled, Double Blind Study of the Protective Effects of EPI-743 (VincerinoneTM) on Noise-Induced Hearing Loss

Edison Pharmaceuticals Inc1 个研究点 分布在 1 个国家目标入组 77 人开始时间: 2014年10月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
77
试验地点
1
主要终点
Pure tone audiometry

研究概览

简要总结

If effective, administration of EPI-743 should have protective effects against temporary noise-induced hearing loss.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy adults ages 18-30
  • Abstention from use of Idebenone, CoQ10, Vitamin E and foods or beverages at least 30 days prior to treatment initiation
  • Non-smokers
  • Abstention from alcohol from day 0 and throughout the duration of study
  • Normal audiology exam
  • Subject must be able to swallow size 0 capsules

排除标准

  • Allergy to EPI-743 or sesame oil or nuts
  • Any medical disordere that would prevent subject participation
  • Any prescription meds other than for contraception or seasonal allergies
  • Any significant patient medical history (cancer, cardiovascular, pulmonary, cognitive, ADHD, hx. of migraines, neurological, kidney)
  • Fat malabsorption syndromes
  • Anticoagulation thereapy within 30 days of enrollment

研究组 & 干预措施

EPI-743

Active Comparator

EPI-743 400 mg P.O. TID

干预措施: EPI-743 (Drug)

Placebo

Placebo Comparator

Sesame Oil, NF in sealed gelatin capsules to match the test product

干预措施: Placebo (Drug)

结局指标

主要结局

Pure tone audiometry

时间窗: 9 days

次要结局

  • Time to recovery following acute noise exposure(9 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验